NewBioWorld A
Journal of Alumni Association of Biotechnology (2022) 4(1):13-19
REVIEW
ARTICLE
Bioactive Compounds and Pharmacological Activities of the
Genus Cordyceps: A Review
Varsha
Meshram* and Nagendra Kumar Chandrawanshi
School of Studies in Biotechnology,
Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, India.
varshameshram2801@gmail.com;
chandrawanshi11@gmail.com
*Corresponding
author Email: varshameshram2801@gmail.com
ARTICLE INFORMATION
|
|
ABSTRACT
|
Article history:
Received
28 March 2022
Received in revised form
17 June 2022
Accepted
Keywords:
Cordyceps species; Bioactive compounds; Extraction process;
Pharmacological activities
|
|
For many years,
traditional Chinese medicine has relied on medicinal fungi to boost the
immune system and revitalize the body due to their diverse biological
functions. Among the medicinal fungi, Cordyceps species have been
particularly valuable because of their bioactive components that are
beneficial for modern medicine and pharmacology. However, most reviews on Cordyceps
have only focused on a few species and their specific pharmacological
effects, leaving many other species unexplored. This review aims to fill this
gap by gathering data on the pharmacological value of various Cordyceps
species and their best extraction process for bioactive compounds. By doing
so, we can uncover potential therapeutic applications of Cordyceps that
have not been explored yet, and contribute to the development of new drugs
and treatments.
|
|
Graphical
Abstract:
1. Introduction
DOI: 10.52228/NBW-JAAB.2022-4-1-4
|
Cordyceps is a highly regarded traditional Chinese medicine that has
been used for centuries. It is made up of dried fungus that grows on the bodies
of caterpillars. The fungus belongs to the Cordyceps genus and is
considered to have many health benefits (Ng and Wang, 2005). The term "Cordyceps"
originates from the fusion of two words: "kordyle," which is a Greek
word that refers to "club," and "ceps," a Latin word that
means "head." Although various species of Cordyceps differ in
terms of their growth location and the type of insects they infect, they share
a comparable life cycle and utilize host organisms for their growth. Cordyceps
typically exist in a dormant state in the soil and become active when they
encounter a suitable host. They are different from other fungi because they
produce a unique fruiting body and are a pathogen of insects and the fungal
genus Elaphomyces. Some Cordyceps species are easier to grow than others
(Kobayasi. Y, 1941). There are around 20 species of Cordyceps that
attack the Elaphomyces fungi, while the rest of the species invade insects and
other arthropods like spiders, beetles, bugs, wasps, termites, and butterflies
(Mains, 1958). Cordyceps are a type of fungus found in many different
parts of the world, particularly in humid, tropical forests and high altitude
on the Himalayan plateau (Borde and Singh, 2022). They are most commonly found
in North America, Europe, and Asian countries like China, Japan, and Korea.
However, other species of Cordyceps have also been discovered in
different environments across the globe, showing that they can grow in many
different places (Winkler, 2010; Panda and Swain, 2011; Holliday and Cleaver,
2008; Li et al., 2022). The two most well-known and researched species of Cordyceps
are C. sinensis and C. militaris. These fungi have been found to
have positive effects on various health conditions such as respiratory, liver,
and kidney problems, heart and lung diseases, high blood sugar, high
cholesterol, and even as potential treatments for cancer (Xiao and Zhong, 2007;
Qu et al., 2022). Fermentation technology has become a popular method for
mass-producing certain species of Cordyceps due to the scarcity and high
cost of natural Cordyceps (Zhang et al., 2019; Sun et al., 2019). This
article provides a comprehensive overview of the pharmacological acitvites of
extracted bioactive compounds of known Cordyceps species.
2. Bioactive
compounds
The different species of Cordyceps produce a wide
variety of chemicals, both in their natural state and when grown in a lab. Some
of the important groups of chemicals found in Cordyceps include
nucleosides, sterols, flavonoids, cyclic peptides, phenolics, bioxanthracenes,
polyketides, and alkaloids. Cyclic peptides are particularly common in Cordyceps.
2.1
Nucleosides
Most of the nucleosides discovered in Cordyceps were
found in C. sinensis, C. militaris, and C. cicadae. Cordycepin
is the most significant nucleoside found in Cordyceps due to its broad
range of pharmacological benefits (Cunningham et al., 1950). Other nucleosides
discovered in Cordyceps include adenine, adenosine, uracil, uridine,
guanidine, guanosine, hypoxanthine, inosine, thymine, thymidine, and
deoxyuridine (Li et al., 2006). These compounds have been shown to have strong
abilities to fight cancer, viruses, inflammation, and tumors, as well as to
protect the brain and act as antioxidants (Liu et al., 2015)
2.2
Polysaccharides
In recent years, scientists have become increasingly
interested in the polysaccharides found in Cordyceps due to their
potential medical benefits. These benefits include anti-tumor, immune-boosting,
anti-oxidant, anti-inflammatory, anti-aging, and anti-fatigue properties (Shin
et al., 2018). Researchers have also found that certain strains of Cordyceps,
such as C. militaris, C. taii and C. guangdongensis (Yan
et al., 2013), have specific effects, such as anti-cancer and
anti-oxidant properties.
2.3 Sterols
Cordyceps species
contain sterol-type compounds that have shown potent anti-tumor activity. The
main sterols found in Cordyceps are ergosterol and ergosterol peroxide,
but other sterols such as 3-sitosterol, campeasterol, daucosterol, and
5α,8α-epidioxy-24(R)-methyl-cholesta-6,22-dien-3β-D-glucopyranoside have also
been discovered (Olatunji et al., 2018). These sterols have various
pharmacological properties, such as cytotoxic, antiviral, antiarrhythmic, and
the ability to alleviate immunoglobulin A nephropathy and suppress activated
human mesangial cells (Li et al., 2006). Some other bioactive compounds are shown
in Table 1.
3. Extraction of Major Compounds from Cordyceps
spp.
Chen et al. (2013) utilized different extraction techniques
to isolate specific bioactive compounds from Cordyceps spp. Aqueous
extraction using water as the extraction medium was standardized by Sun et al.
(2003), yielding between 25-30% and displaying antioxidant activity. Alcoholic
extraction with methanol, ethanol, aqueous methanol, and aqueous ethanol was
found to be effective in extracting nucleosides, polysaccharides, and proteins,
resulting in strong antioxidant activity and cytotoxic effects on cancer cells
(Yamaguchi et al., 2000; Jia et al., 2009). Ethyl acetate extraction, despite
its low yield, was able to isolate important bioactive components such as
ergosterol, cordycepin, and adenosine, and exhibited anticancer and antioxidant
activities (Zhang et al., 2004; Wu et al., 2007; Wu et al., 2006).
Supercritical CO2 extraction, a highly efficient and pure method,
was able to extract non-polar bioactive compounds from Cordyceps and
showed potent scavenging abilities and the ability to inhibit cancer cell
proliferation (Wang et al., 2005).
4. Pharmacological activities
Cordyceps has been
shown to have various pharmacological activities, including anti-inflammatory,
antioxidant, immunomodulatory, anti-tumor, anti-viral, anti-microbial,
anti-diabetic, anti-fatigue, and anti-aging effects. Table 2 represents
the pharmacological activities of Cordyceps species.
Table 1: Bioactive compounds of Cordyceps species.
S.No.
|
Bioactive
compounds
|
Species
|
References
|
1.
|
Cordycepin
|
C.sinesis
|
Cunningham, 1950
|
2.
|
Cordymin
|
C.sinesis
|
Qian et al., 2015; Wang et al., 2012
|
3.
|
Ergosterol
|
C.militaris,
|
Sun et al., 2019
|
4.
|
Cordysinin A
|
C.sinesis
|
Yang et al., 2011
|
5.
|
Cordysinin B
|
C.sinesis
|
Yang et al., 2011
|
6.
|
5α,8α-epidioxy-22E-ergosta-6,22-dien-3β-ol
|
C.sinesis
|
Matsuda et al., 2009
|
7.
|
5α,8α-epidioxy-22E-ergosta-6,9(11),22-trien-3β-ol
|
C.sinesis
|
Matsuda et al., 2009
|
8.
|
Cordycepic acid
|
C.sinesis
|
Liu et al., 2015
|
9.
|
Fumosoroseain A
|
C. fumosorosea
|
Buchter et al., 2020
|
10.
|
Fumosoroseanoside A
|
C. fumosorosea
|
Buchter et al., 2020
|
11.
|
Trichocaranes
|
C. fumosorosea
|
Chen et al., 2018
|
12.
|
Terreusinone A
|
C. gracilioides
|
Wei et al., 2015
|
13.
|
Pinophilin C
|
C. gracilioides
|
Wei et al., 2015
|
14.
|
Beauvericin J
|
C. cicadae
|
Wang et al., 2014
|
15.
|
3,4-dihydroxy-8-hydroxy-3-(2-hydroxypentyl)-6-methoxyisocoumarin
|
C.militaris
|
Haritakun et al., 2010
|
16.
|
Luteoride D
|
C. gunnii
|
Qu et al., 2022
|
17.
|
Pseurotin G
|
C. gunnii
|
Qu et al., 2022
|
18.
|
Bianthraquinone
|
C. morakotii
|
Wang et al., 2019
|
19.
|
Cordycicadins A-D
|
C. cicadae
|
Li et al., 2022
|
20.
|
Cytochalasin
|
C. taii
|
Li et al., 2015
|
Table 2: The Pharmacological activities of Cordyceps species
Species
|
Host
|
Pharmacological
activities
|
References
|
C. annullata
|
Plesiophthalmus nigrocyaneus and Coleopterah
|
Agonistic activity against cannabinoid receptor
|
Asai et al., 2012
|
C. pseudomilitaris
|
Lepidoptera
|
Antimalarial, cytotoxicity
|
Jaturapat et al., 2001
|
C. bassiana
|
Lepidoptera
|
Anti-inflammatory, antiproliferative and pro-apoptotic
properties
|
Kim et al. 2015; Kim et al., 2014
|
C. cardinalis
|
Lepidopteran
|
Antitrypanosomal activity
|
Umeyama et al., 2014
|
C. cicadae
|
Icada flammat
|
Antitumor, antibacterial, immunoregulatory,
renoprotective, cytotoxic and sedative effects
|
Kuo et al., 2003; Zhu et al., 2014
|
C. communis
|
Isoptera
|
Antitubercular
|
Haritakun et al., 2010
|
C. kyushuensis
|
Clanis bilineata
|
Antioxidant and antitumor activity
|
Zhang et al., 2015
|
C. dipterigena
|
-
|
Antifungal
|
Varughese et al., 2012
|
C. guangdongensis
|
Elaphomyces
|
Anti-fatigue, antioxidant, prolonging life, anti-avian
influenza, anti-inflammatory and in the treatment of chronic renal failure
|
Yan et al., 2013; Yan and Zhong, 2014
|
C. japonica
|
Silkworm
|
Antioxidant, immunostimulating, antiaging and antitumor
activities
|
Shin et al., 2001; Shin et al., 2003
|
C. lanpingensis
|
Hepialidae
|
-
|
Chen et al., 2013
|
C. militaris
|
Silkworm
|
Hypoglycemic, hypolipidemic, anti-inflammatory, antitumor,
antibacterial, antifungal, marcrophage activation, antiviral, antimicrobial,
antiprotozoal, prosexual, antimalarial, anti-HIV, neuroprotective,
antioxidant and immuno-protective activities
|
Das et al., 2010; Reis et al., 2013
|
C. ophioglossoides
|
Carpinus cordata
|
Antitumor, estrogenic, antioxidant and anti-ageing
activities
|
Kawagishi et al., 2004;
Qinqin et al., 2012
|
C. pruinosa
|
Lepidoptera
|
Anti-proliferative properties
|
Liu et al., 2001
|
C. sinensis
|
Lepidoptera
|
Antitumor, cerebroprotective, antiaging, gastroprotective,
immunomodulatory, antioxidant, anti-inflammatory, antidiabetic, aphrodisiac,
antiproliferative and anti-fatigue activities
|
Sun et al., 2014; Jin et
al., 2004; Wang et al., 2015; wang et al., 2005; Xiang et al., 2016; Lu et
al., 2014
|
C. sobolifera
|
Cicada nymphs
|
Renoprotective, HIV-1 reverse transcriptase- Inhibitory
activity
|
Chyau et al., 2014; Chiu et
al., 2014; Wang et al., 2014
|
C. sphecocephala
|
Wasps and bees
|
Anticancer and anti-asthmatic activities
|
Hywel, 1995; Heo et al.,
2010; Oh et al., 2008
|
C. unilateralis
|
Ants
|
Antimalarial and anticancer activities
|
Kittakoop et al., 1999
|
5. Future prospect and Conclusion
Although Cordyceps is generally considered safe, most
of the research conducted on its pharmacological properties has been in
laboratory settings. Further studies are required to confirm the fungus's
safety, toxicity, and potential clinical efficacy in vivo. Moreover,
more detailed documentation of the traditional uses of various Cordyceps
species is necessary to guide future research into their biological activities and
the identification of bioactive compounds for the development of new drugs.
While earlier reviews have primarily focused on a small number of Cordyceps
species, including C. militaris and C. sinensis, this review
presents a comprehensive summary of many other species to assist researchers in
identifying promising species or compounds for further investigation.
Conflict of
interest
Authors had no
conflict of interest.
Acknowledgements
The authors are thankful to the Head, School of Studies in
Biotechnology, Pt. Ravishankar Shukla University Raipur, for providing
necessary facilities. All figures were created with BioRender.com.
Funding supports
The authors wish to acknowledge the Junior Research
Fellowship (No. F. 82-44/2020 (SA-III, UGC-Ref. No.: 201610136180), Ministry of
Education, Govt. of India, Bahadurshah Zafar Marg, New Delhi-110002, for
providing funding support.
References
Asai,
T., Luo, D., Obara, Y., Taniguchi, T., Monde, K., Yamashita, K. and Oshima, Y.
(2012). Dihydrobenzofurans as cannabinoid receptor ligands from Cordyceps
annullata, an entomopathogenic fungus cultivated in the presence of an HDAC
inhibitor. Tetrahedron Letters, 53(17), 2239-2243.
Borde,
M. and Singh, S. K. (2022). Prospects of Cordycepin and Polysaccharides
Produced by Cordyceps. Fungal Diversity, Ecology and Control
Management, 93-107.
Buchter,
C., Koch, K., Freyer, M., Baier, S., Saier, C., Honnen, S. and Watjen, W.
(2020). The mycotoxin beauvericin impairs development, fertility and life span
in the nematode Caenorhabditis elegans accompanied by increased germ
cell apoptosis and lipofuscin accumulation. Toxicology Letters, 334,
102-109.
Chen,
C., Xue, T., Fan, P., Meng, L., Wei, J. and Luo, D. (2018). Cytotoxic activity
of Shp2 inhibitor fumosorinone in human cancer cells. Oncology Letters, 15(6),
10055-10062.
Chen,
P. X., Wang, S., Nie, S. and Marcone, M. (2013). Properties of Cordyceps
sinensis: a review. Journal of Functional Foods, 5(2),
550-569.
Chen,
Z. H., Dai, Y. D., Yu, H., Yang, K., Yang, Z. L., Yuan, F. and Zeng, W. B.
(2013). Systematic analyses of Ophiocordyceps lanpingensis sp. nov., a
new species of Ophiocordyceps in China. Microbiological Research, 168(8),
525-532.
Chiu,
C. H., Chyau, C. C., Chen, C. C., Lin, C. H., Cheng, C. H. and Mong, M. C.
(2014). Polysaccharide extract of Cordyceps sobolifera attenuates renal
injury in endotoxemic rats. Food and Chemical Toxicology, 69,
281-288.
Chyau,
C. C., Chen, C. C., Chen, J. C., Yang, T. C., Shu, K. H. and Cheng, C. H.
(2014). Mycelia glycoproteins from Cordyceps sobolifera ameliorate
cyclosporine-induced renal tubule dysfunction in rats. Journal of
Ethnopharmacology, 153(3), 650-658.
Cunningham,
K. G., Manson, W., Spring, F. S. and Hutchinson, S. A. (1950). Cordycepin, a
metabolic product isolated from cultures of Cordyceps militaris (Linn.)
Link. Nature, 166, 949-949.
Das,
S. K., Masuda, M., Sakurai, A. and Sakakibara, M. (2010). Medicinal uses of the
mushroom Cordyceps militaris: current state and prospects. Fitoterapia, 81(8),
961-968.
Haritakun,
R., Sappan, M., Suvannakad, R., Tasanathai, K. and Isaka, M. (2010). An
antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps
communis BCC 16475. Journal of Natural Products, 73(1),
75-78.
Heo,
J. C., Nam, S. H., Nam, D. Y., Kim, J. G., Lee, K. G., Yeo, J. H., Yoon, C.S.,
Park, C.H. and Lee, S. H. (2010). Anti-asthmatic activities in mycelial extract
and culture filtrate of Cordyceps sphecocephala J201. International
Journal of Molecular Medicine, 26(3), 351-356.
Holliday,
J. and Cleaver, M. P. (2008). Medicinal value of the caterpillar fungi species
of the genus Cordyceps (Fr.) Link (Ascomycetes). A review. International
Journal of Medicinal Mushrooms, 10(3).
Hywel-Jones,
N. (1995). Cordyceps sphecocephala and a Hymenostilbe sp.
infecting wasps and bees in Thailand. Mycological Research, 2(99),
154-158.
Jaturapat,
A., Isaka, M., Hywel-Jones, N. L., Lertwerawat, Y., Kamchonwongpaisan, S.,
Kirtikara, K., Tanticharoen, M. and Thebtaranonth, Y. (2001). Bioxanthracenes
from the insect pathogenic fungus Cordyceps pseudomilitaris BCC 1620 I.
Taxonomy, fermentation, isolation and antimalarial activity. The
Journal of Antibiotics, 54(1), 29-35.
Jia,
J. M., Tao, H. H. and Feng, B. M. (2009). Cordyceamides A and B from the
Culture Liquid of Cordyceps sinensis (B ERK.) S ACC. Chemical
and Pharmaceutical Bulletin, 57(1), 99-101.
Jin,
D. Q., Park, B. C., Lee, J. S., Choi, H. D., Lee, Y. S., Yang, J. H. and Kim,
J. A. (2004). Mycelial extract of Cordyceps ophioglossoides prevents
neuronal cell death and ameliorates β-amyloid peptide-induced memory deficits
in rats. Biological and Pharmaceutical Bulletin, 27(7),
1126-1129.
Kawagishi,
H., Okamura, K., Kobayashi, F. and Kinjo, N. (2004). Estrogenic substances from
the mycelia of medicinal fungus Cordyceps ophioglossoides (ehrh.) Fr
(Ascomycetes). International Journal of Medicinal Mushrooms, 6(3).
Kim,
J. H., Lee, Y., Sung, G. H., Kim, H. G., Jeong, D., Park, J. G., Baek, K.S.,
Sung, N.Y., Yang, S., Yoon, D.H., Lee, S.Y. and Cho, J. Y. (2015).
Antiproliferative and apoptosis-inducing activities of 4-isopropyl-2, 6-bis
(1-phenylethyl) phenol isolated from butanol fraction of Cordyceps bassiana. Evidence-Based
Complementary and Alternative Medicine, 2015.
Kim,
T. W., Yoon, D. H., Cho, J. Y. and Sung, G. H. (2014). Anti‐inflammatory
compounds from Cordyceps bassiana (973.3). The FASEB Journal, 28,
973-3.
Kittakoop,
P., Punya, J., Kongsaeree, P., Lertwerawat, Y., Jintasirikul, A., Tanticharoen,
M. and Thebtaranonth, Y. (1999). Bioactive naphthoquinones from Cordyceps
unilateralis. Phytochemistry, 52(3), 453-457.
Kobayasi,
Y. (1941). The genus Cordyceps and its allies. Science reports
of the Tokyo Bunrika Daigaku sect. B, 84, 53-260.
Kuo,
Y. C., Weng, S. C., Chou, C. J., Chang, T. T. and Tsai, W. J. (2003).
Activation and proliferation signals in primary human T lymphocytes inhibited
by ergosterol peroxide isolated from Cordyceps cicadae. British
Journal of Pharmacology, 140(5), 895.
Li, S.
P., Yang, F. Q. and Tsim, K. W. (2006). Quality control of Cordyceps
sinensis, a valued traditional Chinese medicine. Journal of
Pharmaceutical and Biomedical Analysis, 41(5), 1571-1584.
Li, X.
G., Pan, W. D., Lou, H. Y., Liu, R. M., Xiao, J. H. and Zhong, J. J. (2015).
New cytochalasins from medicinal macrofungus Crodyceps taii and their
inhibitory activities against human cancer cells. Bioorganic &
Medicinal Chemistry Letters, 25(9), 1823-1826.
Li,
X., Chen, H. P., Zhou, L., Fan, J., Awakawa, T., Mori, T., Ushimaru, R., Abe,
I. and Liu, J. K. (2022). Cordycicadins A–D, Antifeedant Polyketides from the
Entomopathogenic Fungus Cordyceps cicadae JXCH1. Organic Letters, 24(47),
8627-8632.
Liu,
J. L. and Fei, Y. (2001). Enhancement of Cordyceps taii polysaccharide
and Cordyceps pruinosa polysaccharide on cellular immune function in
vitro. Immunol J, 17, 189-191.
Liu,
Y., Wang, J., Wang, W., Zhang, H., Zhang, X. and Han, C. (2015). The chemical
constituents and pharmacological actions of Cordyceps sinensis. Evidence-Based
Complementary and Alternative Medicine, 2015.
Lu, W.
J., Chang, N. C., Jayakumar, T., Liao, J. C., Lin, M. J., Wang, S. H., Chou,
D.S., Thomas, P.A. and Sheu, J. R. (2014). Ex vivo and in vivo
studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps
sinensis that inhibits human platelet activation by activating adenylate
cyclase/cyclic AMP. Thrombosis Research, 134(6),
1301-1310.
Mains,
E. B. (1958). North American entomogenous species of Cordyceps. Mycologia, 50(2),
169-222.
Matsuda,
H., Akaki, J., Nakamura, S., Okazaki, Y., Kojima, H., Tamesada, M. and Yoshikawa,
M. (2009). Apoptosis-inducing effects of sterols from the dried powder of
cultured mycelium of Cordyceps sinensis. Chemical and
Pharmaceutical Bulletin, 57(4), 411-414.
Ng, T.
B. and Wang, H. X. (2005). Pharmacological actions of Cordyceps, a prized
folk medicine. Journal of Pharmacy and Pharmacology, 57(12),
1509-1519.
Oh, J.
Y., Baek, Y. M., Kim, S. W., Hwang, H. J., Hwang, H. S., Lee, S. H. and Yun, J.
W. (2008). Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma
(SK-N-SH) cells induced by polysaccharides-peptide complexes produced by
submerged mycelial culture of an entomopathogenic fungus Cordyceps
sphecocephala. Journal of Microbiology and Biotechnology, 18(3),
512-519.
Olatunji,
O. J., Tang, J., Tola, A., Auberon, F., Oluwaniyi, O. and Ouyang, Z. (2018).
The genus Cordyceps: An extensive review of its traditional uses,
phytochemistry and pharmacology. Fitoterapia, 129,
293-316.
Panda,
A. K. and Swain, K. C. (2011). Traditional uses and medicinal potential of Cordyceps
sinensis of Sikkim. Journal of Ayurveda and Integrative Medicine, 2(1),
9.
Qian,
G. M., Pan, G. F. and Guo, J. Y. (2012). Anti-inflammatory and antinociceptive
effects of cordymin, a peptide purified from the medicinal mushroom Cordyceps
sinensis. Natural Product Research, 26(24), 2358-2362.
Qinqin,
X. U., Zhenhua, L. I. U., Yisheng, S. U. N., Zhongjie, D. I. N. G., Longxian,
L. U. and Yongquan, L. I. (2012). Optimization for Production of Intracellular
Polysaccharide from Cordyceps ophioglossoides L2 in submerged culture
and its antioxidant activities in vitro. Chinese Journal of
Chemical Engineering, 20(2), 294-301.
Qu, S.
L., Xie, J., Wang, J. T., Li, G. H., Pan, X. R., & Zhao, P. J. (2022).
Activities and metabolomics of Cordyceps gunnii under different culture
conditions. Frontiers in Microbiology, 13.
Reis,
F. S., Barros, L., Calhelha, R. C., Ciric, A., Van Griensven, L. J., Sokovic,
M. and Ferreira, I. C. (2013). The methanolic extract of Cordyceps militaris
(L.) Link fruiting body shows antioxidant, antibacterial, antifungal and
antihuman tumor cell lines properties. Food and Chemical Toxicology, 62,
91-98.
Shin,
J. S., Chung, S. H., Lee, W. S., Lee, J. Y., Kim, J. L. and Lee, K. T. (2018).
Immunostimulatory effects of cordycepin‐enriched WIB‐801CE from Cordyceps
militaris in splenocytes and cyclophosphamide‐induced immunosuppressed
mice. Phytotherapy Research, 32(1), 132-139.
Shin,
K. H., Lim, S. S., Lee, S. H., Lee, Y. S. and Cho, S. Y. (2001). Antioxidant
and immunostimulating activities of the fruiting bodies of Paecilomyces
japonica, a new type of Cordyceps sp. Annals of the New York
Academy of Sciences, 928(1), 261-273.
Shin,
K. H., Lim, S. S., Lee, S., Lee, Y. S., Jung, S. H. and Cho, S. Y. (2003).
Anti‐tumour and immuno‐stimulating activities of the fruiting bodies of Paecilomyces
japonica, a new type of Cordyceps spp. Phytotherapy Research, 17(7),
830-833.
Sun,
X., Feng, X., Zheng, D., Li, A., Li, C., Li, S. and Zhao, Z. (2019). Ergosterol
attenuates cigarette smoke extract-induced COPD by modulating inflammation,
oxidative stress and apoptosis in vitro and in vivo. Clinical
Science, 133(13), 1523-1536.
Sun,
Y. S., Lv, L. X., Zhao, Z., He, X., You, L., Liu, J. K. and Li, Y. Q. (2014).
Cordycepol C induces caspase-independent apoptosis in human hepatocellular carcinoma
HepG2 cells. Biological and Pharmaceutical Bulletin, 37(4),
608-617.
Sun,
Y., Zhang, X. and Lei, P. (2003). Study on character for separation and
extraction of polysaccharide from hyphae of Cordyceps sinersis. Acta
Chin. Med. Pharmacol, 2(3).
Umeyama,
A., Takahashi, K., Grudniewska, A., Shimizu, M., Hayashi, S., Kato, M.,
Okamoto, Y., Suenaga, M., Ban, S., Kumada, T. and Ishiyama, A. and Hashimoto,
T. (2014). In vitro antitrypanosomal activity of the cyclodepsipeptides,
cardinalisamides A–C, from the insect pathogenic fungus Cordyceps cardinalis
NBRC 103832. The Journal of Antibiotics, 67(2),
163-166.
Varughese,
T., Rios, N., Higginbotham, S., Arnold, A. E., Coley, P. D., Kursar, T. A.
Gerwick, W.H. and Rios, L. C. (2012). Antifungal depsidone metabolites from Cordyceps
dipterigena, an endophytic fungus antagonistic to the phytopathogen
Gibberella fujikuroi. Tetrahedron Letters, 53(13),
1624-1626.
Wang,
B. J., Won, S. J., Yu, Z. R., & Su, C. L. (2005). Free radical scavenging
and apoptotic effects of Cordyceps sinensis fractionated by
supercritical carbon dioxide. Food and Chemical Toxicology, 43(4),
543-552.
Wang,
J., Kan, L., Nie, S., Chen, H., Cui, S. W., Phillips, A. O., Phillips, G.O.,
Li, Y. and Xie, M. (2015). A comparison of chemical composition, bioactive
components and antioxidant activity of natural and cultured Cordyceps
sinensis. LWT-Food Science and Technology, 63(1),
2-7.
Wang,
J., Liu, Y. M., Cao, W., Yao, K. W., Liu, Z. Q. and Guo, J. Y. (2012).
Anti-inflammation and antioxidant effect of Cordymin, a peptide purified from
the medicinal mushroom Cordyceps sinensis, in middle cerebral artery
occlusion-induced focal cerebral ischemia in rats. Metabolic Brain
Disease, 27, 159-165.
Wang,
J., Zhang, D. M., Jia, J. F., Peng, Q. L., Tian, H. Y., Wang, L. and Ye, W. C.
(2014). Cyclodepsipeptides from the ascocarps and insect-body portions of
fungus Cordyceps cicadae. Fitoterapia, 97, 23-27.
Wang,
M., Kornsakulkarn, J., Srichomthong, K., Feng, T., Liu, J. K., Isaka, M. and
Thongpanchang, C. (2019). Antimicrobial anthraquinones from cultures of the ant
pathogenic fungus Cordyceps morakotii BCC 56811. The Journal of
Antibiotics, 72(3), 141-147.
Wang,
S. X., Liu, Y., Zhang, G. Q., Zhao, S., Xu, F., Geng, X. L. and Wang, H. X.
(2012). Cordysobin, a novel alkaline serine protease with HIV-1 reverse
transcriptase inhibitory activity from the medicinal mushroom Cordyceps
sobolifera. Journal of Bioscience and Bioengineering, 113(1),
42-47.
Wang,
Y., Wang, Y., Liu, D., Wang, W., Zhao, H., Wang, M. and Yin, H. (2015). Cordyceps
sinensis polysaccharide inhibits PDGF-BB-induced inflammation and ROS
production in human mesangial cells. Carbohydrate Polymers, 125,
135-145.
Wei,
P. Y., Liu, L. X., Liu, T., Chen, C., Luo, D. Q., & Shi, B. Z. (2015).
Three new pigment protein tyrosine phosphatases inhibitors from the insect
parasite fungus Cordyceps gracilioides: terreusinone A, pinophilin C and
cryptosporioptide A. Molecules, 20(4), 5825-5834.
Winkler,
D. (2010). Cordyceps sinensis—a precious parasitic fungus infecting
Tibet. Field Mycology, 11(2), 60.
Wu, J.
Y., Zhang, Q. X. and Leung, P. H. (2007). Inhibitory effects of ethyl acetate
extract of Cordyceps sinensis mycelium on various cancer cells in
culture and B16 melanoma in C57BL/6 mice. Phytomedicine, 14(1),
43-49.
Wu,
Y., Sun, H., Qin, F., Pan, Y. and Sun, C. (2006). Effect of various extracts
and a polysaccharide from the edible mycelia of Cordyceps sinensis on
cellular and humoral immune response against ovalbumin in mice. Phytotherapy
Research: An International Journal Devoted to Pharmacological and Toxicological
Evaluation of Natural Product Derivatives, 20(8), 646-652.
Xiang,
F., Lin, L., Hu, M. and Qi, X. (2016). Therapeutic efficacy of a polysaccharide
isolated from Cordyceps sinensis on hypertensive rats. International
Journal of Biological Macromolecules, 82, 308-314.
Xiao,
J. H. and Zhong, J. J. (2007). Secondary metabolites from Cordyceps
species and their antitumor activity studies. Recent Patents on
Biotechnology, 1(2), 123-137.
Yamaguchi,
Y., Kagota, S., Nakamura, K., Shinozuka, K. and Kunitomo, M. (2000).
Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps
sinensis. Phytotherapy Research: An International Journal Devoted
to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 14(8),
647-649.
Yan,
W., Li, T. and Zhong, Z. (2014). Anti-inflammatory effect of a novel food Cordyceps
guangdongensis on experimental rats with chronic bronchitis induced by
tobacco smoking. Food and Function, 5(10), 2552-2557.
Yan,
W., Li, T., Lao, J., Song, B. and Shen, Y. (2013). Anti-fatigue property of Cordyceps
guangdongensis and the underlying mechanisms. Pharmaceutical
Biology, 51(5), 614-620.
Yang,
M. L., Kuo, P. C., Hwang, T. L. and Wu, T. S. (2011). Anti-inflammatory
principles from Cordyceps sinensis. Journal of Natural Products, 74(9),
1996-2000.
Zhang,
G., Yin, Q., Han, T., Zhao, Y., Su, J., Li, M. and Ling, J. (2015).
Purification and antioxidant effect of novel fungal polysaccharides from the
stroma of Cordyceps kyushuensis. Industrial Crops and Products, 69,
485-491.
Zhang,
J., Wen, C., Duan, Y., Zhang, H. and Ma, H. (2019). Advance in Cordyceps
militaris (Linn) Link polysaccharides: Isolation, structure, and
bioactivities: A review. International Journal of Biological
Macromolecules, 132, 906-914.
Zhang,
Q., Wu, J., Hu, Z. and Li, D. (2004). Induction of HL-60 apoptosis by ethyl
acetate extract of Cordyceps sinensis fungal mycelium. Life
sciences, 75(24), 2911-2919.
Zhu,
R., Zheng, R., Deng, Y., Chen, Y. and Zhang, S. (2014). Ergosterol peroxide
from Cordyceps cicadae ameliorates TGF-β1-induced activation of kidney
fibroblasts. Phytomedicine, 21(3), 372-378.